ROTHSCHILD & CO EQUITY MARKETS SOLUTIONS LIMITED

Executive Summary

ROTHSCHILD & CO EQUITY MARKETS SOLUTIONS LIMITED is currently in an early, dormant phase with minimal financial data, limiting assessment of its financial health. The company shows good compliance and strong leadership but needs to progress to active trading and comprehensive financial reporting to provide a clearer picture of operational sustainability. With careful monitoring and strategic financial management, it can build a solid financial foundation.

ROTHSCHILD & CO EQUITY MARKETS SOLUTIONS LIMITED - Analysis Report

Company Number: 13317911

Analysis Date: 2025-07-20 11:01 UTC

Financial Health Assessment: ROTHSCHILD & CO EQUITY MARKETS SOLUTIONS LIMITED

---

1. Financial Health Score: D

Explanation:
This company, incorporated in 2021, currently holds minimal financial data with only a dormant account filed for 2021 showing net assets and shareholder funds of £1. There is no substantive financial activity recorded, and the lack of meaningful financial data beyond the dormant status limits a positive health assessment. This is akin to a patient who has yet to undergo a full health checkup—there is insufficient information to confirm good health or identify risks. The score reflects the early and inactive state of the company rather than distress or insolvency.

---

2. Key Vital Signs

Vital Sign	Value/Status	Interpretation
Company Status	Active	The company is operational, not dissolved or in liquidation.
Financial Activity	Dormant (2021 accounts)	No significant trading or financial transactions recorded in first year.
Share Capital	£9.00	Nominal capital; typical for a newly incorporated private limited company.
Net Assets (2021)	£1	Minimal net assets; consistent with dormant status.
Filing Compliance	Up-to-date (Accounts & Returns)	No overdue filings, indicating good compliance discipline.
Industry Classification	Financial intermediation not elsewhere classified (SIC 64999)	Suggests intended activity in financial services sector.
Director Appointments	Multiple current directors with finance-related occupations	Strong leadership with relevant expertise on board.

---

3. Diagnosis

The financial "vital signs" indicate this company is in an embryonic stage with no active trading or substantive financial transactions reported so far. The filed accounts are dormant, showing only nominal share capital and net assets. This "symptom" suggests the company is either in a preparatory phase or holding assets/rights without commercial activity.

The presence of experienced directors and good compliance with filing deadlines are positive indicators. However, the absence of financial data such as turnover, profit/loss, assets, liabilities, or cash flow means we cannot evaluate the company's operational sustainability or profitability.

In medical terms, the company's financial health resembles a patient in baseline observation with no acute illness but no measurable health improvements or deterioration. Without further data on cash flow, income statements, or balance sheets for subsequent years, it is impossible to assess operational health or risks.

---

4. Recommendations

• Activate Financial Reporting: As the company moves beyond dormancy, it is critical to file full financial statements that reflect trading activities, including profit and loss accounts and cash flow statements. This will provide clearer financial vital signs.

• Monitor Cash Flow Closely: Once active, ensure the company maintains a healthy cash flow to avoid symptoms of financial distress such as liquidity crunches or working capital shortages.

• Enhance Asset Management: Track fixed and current assets to build a robust balance sheet and strengthen net asset position.

• Maintain Compliance: Continue timely filing of accounts and confirmation statements to avoid regulatory penalties and maintain stakeholder trust.

• Engage in Strategic Planning: With a strong team of finance professionals on the board, develop medium-term financial plans, including budgeting and forecasting, to anticipate capital needs and operational costs.

• Consider External Audit: Once trading commences, consider an audit to provide independent assurance on financial health, reassuring investors and creditors.

---